Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study

Background: Treating chronic urticaria (CU) that is unresponsive to H1-antihistamines (H1AHs) is challenging, and the real-world effectiveness of omalizumab remains unclear. Objective: Our aim was to evaluate the real-world effectiveness of omalizumab, optimal response assessment timing, and predict...

Full description

Bibliographic Details

Published in:	Journal of Allergy and Clinical Immunology: Global
Main Authors:	Hyun-Young Lee, PhD, Hyun-Seob Jeon, MD, Jae-Hyuk Jang, MD, Youngsoo Lee, MD, Yoo Seob Shin, MD, PhD, Dong-Ho Nahm, MD, PhD, Hae-Sim Park, MD, PhD, Young-Min Ye, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Subjects:	Chronic urticaria omalizumab treatment response predictor total IgE
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772829324000419